The development of alternative, patient-friendly drug delivery routes for peptide-based therapeutics continues to be a major focus in pharmaceutical research. At the Drug Delivery to the Lungs (DDL) Conference 2025, a peer-reviewed study presented by Glieca et al. explored an innovative approach to delivering semaglutide, a widely used GLP-1 receptor agonist, via the pulmonary route. […]
